Literature DB >> 18556182

[Hereditary spherocytosis: guidelines for the diagnosis and management in children].

C Guitton1, L Garçon, T Cynober, F Gauthier, G Tchernia, J Delaunay, T Leblanc, I Thuret, B Bader-Meunier.   

Abstract

Hereditary spherocytosis (HS) is the commonest inherited disorder of the erythrocyte membrane in Northern Europe and North America. It is marked by a regenerative anemia which varies widely from asymptomatic patients to severe hemolysis. In 75% of HS patients, inheritance is autosomal dominant. The diagnosis of HS is easily made when there are a family history, hemolytic anemia, reticulocytosis, spherocytes and increased hyperdense cells. Specialized testing to clarify the nature of membrane disorder is required when the film appearance is atypical without a positive family history, in the absence of a family history, in the newborn and before the splenectomy, to rule out the stomatocytosis which is contraindicated. The indication for splenectomy is dependent on the degree of anemia and its clinical manifestation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18556182     DOI: 10.1016/j.arcped.2008.04.023

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  3 in total

1.  Long-term follow-up of subtotal splenectomy for hereditary spherocytosis: a single-center study.

Authors:  Thomas Pincez; Corinne Guitton; Frédéric Gauthier; Guénolée de Lambert; Véronique Picard; Madeleine Fénéant-Thibault; Ali Turhan; Narla Mohandas; Gil Tchernia; Loïc Garçon
Journal:  Blood       Date:  2016-01-15       Impact factor: 22.113

2.  Laparoscopic splenectomy in patients with hereditary spherocytosis: report on 12 consecutive cases.

Authors:  R Vecchio; Eva Intagliata; F Ferla; S Marchese; R R Cacciola; E Cacciola
Journal:  Updates Surg       Date:  2013-10-16

3.  Diagnostic tool for red blood cell membrane disorders: Assessment of a new generation ektacytometer.

Authors:  Lydie Da Costa; Ludovic Suner; Julie Galimand; Amandine Bonnel; Tiffany Pascreau; Nathalie Couque; Odile Fenneteau; Narla Mohandas
Journal:  Blood Cells Mol Dis       Date:  2015-09-16       Impact factor: 3.039

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.